Last reviewed · How we verify
NCT05831241
Effects of Ashwagandha Extract (Capsule KSM-66 300 mg) on Sexual Health in Healthy Women
NA trial testing Ashwagandha in Sexual Health in 45 participants. Completed in 20 December 2024.
12 October 2023
Quick facts
| Lead sponsor | SF Research Institute, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 45 |
| Start date | 12 July 2023 |
| Primary completion | 12 October 2023 |
| Estimated completion | 20 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Ashwagandha — full drug profile →
- Placebo
Conditions studied
- Sexual Health — all drugs for Sexual Health →
Sponsor
SF Research Institute, Inc.
Who can join
Adults 18 to 55, female only, with Sexual Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The clinical study aims to evaluate Efficacy and Safety of KSM66 Ashwagandha Standardized Root Extract for Improving Sexual Health in Healthy Women by measuring the sex hormone levels in blood, analyzing results of questionnaires, and monitoring adverse events in the post-marketing phase. Changes in sex hormone levels in blood may affect sexual health or sexual health satisfaction. Efficacy is defined as increase in sex hormone levels in blood, and improvements in results or scores in assessment questionnaires.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Emerging Vistas for the Nutraceutical <i>Withania somnifera</i> in Inflammaging.
Basudkar V, Gujrati G, Ajgaonkar S, Gandhi M, et al · · 2024 · cited 17× · PMID 38794167 · DOI 10.3390/ph17050597
Verify or expand the search:
- PubMed search for NCT05831241
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ashwagandha
Trials testing the same drug.
- NCT07151261 — Ashwagandha for Nighttime Waking · NA · active not recruiting
- NCT06900569 — Ashwagandha Supplementation for Prevention of Muscle Damage · NA · completed
- NCT05610735 — Combination Therapy for Recurrent Ovarian Cancer · Phase 1, PHASE2 · recruiting
- NCT06264986 — The Effects of Ashwagandha (Withania Somnifera) Supplementation on Exercise Performance in Female Footballers · NA · completed
- NCT05840731 — Role of Ashwagandha Extract (Capsule KSM-66 300 mg) in Improving Sexual Health in Healthy Men · Phase 4 · unknown
Other recruiting trials for Sexual Health
Currently open trials in the same condition.
- NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
- NCT07011563 — Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health · NA · recruiting
- NCT05852600 — Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents · NA · active not recruiting
- NCT05689775 — Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap · recruiting
Other SF Research Institute, Inc. trials
Trials by the same sponsor.
- NCT07441070 — Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress · NA · enrolling by invitation
- NCT07441096 — Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women · NA · not yet recruiting
- NCT07441083 — Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness · NA · not yet recruiting
- NCT07441109 — Shatavari Root Extract for Perimenopausal Symptoms · NA · not yet recruiting
- NCT07421596 — An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05831241 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SF Research Institute, Inc.
- Last refreshed: 11 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05831241.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing